Marwa M. M. Refaie

612 total citations
30 papers, 480 citations indexed

About

Marwa M. M. Refaie is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Reproductive Medicine. According to data from OpenAlex, Marwa M. M. Refaie has authored 30 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 12 papers in Cardiology and Cardiovascular Medicine and 6 papers in Reproductive Medicine. Recurrent topics in Marwa M. M. Refaie's work include Cardiac Ischemia and Reperfusion (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). Marwa M. M. Refaie is often cited by papers focused on Cardiac Ischemia and Reperfusion (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). Marwa M. M. Refaie collaborates with scholars based in Egypt, Saudi Arabia and Japan. Marwa M. M. Refaie's co-authors include Seham A. Abdel-Gaber, Asmaa M. A. Bayoumi, Nashwa Fathy Gamal El‐Tahawy, Aly M. Abdelrahman, Entesar F. Amin, Amr A. Fouad, Wedad M. Abdelraheem, Rehab Ahmed Rifaai, Sara Mohamed Naguib Abdel Hafez and Noha A. Hassuna and has published in prestigious journals such as Life Sciences, Toxicology and Biomedicine & Pharmacotherapy.

In The Last Decade

Marwa M. M. Refaie

29 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marwa M. M. Refaie Egypt 13 131 121 121 71 60 30 480
Seham A. Abdel-Gaber Egypt 15 141 1.1× 109 0.9× 62 0.5× 35 0.5× 88 1.5× 29 461
Asmaa Mohamed Abdel‐Aziz Egypt 15 111 0.8× 74 0.6× 30 0.2× 96 1.4× 45 0.8× 30 501
Lihua Wang China 11 132 1.0× 55 0.5× 48 0.4× 94 1.3× 51 0.8× 33 498
Asmaa M. A. Bayoumi Egypt 13 112 0.9× 89 0.7× 72 0.6× 16 0.2× 38 0.6× 26 408
Abdülkerim Bedir Türkiye 15 224 1.7× 85 0.7× 63 0.5× 13 0.2× 86 1.4× 60 725
Natalia Nuño‐Lámbarri Mexico 17 275 2.1× 51 0.4× 56 0.5× 32 0.5× 106 1.8× 46 815
Jah‐Yao Liu Taiwan 12 187 1.4× 54 0.4× 32 0.3× 84 1.2× 85 1.4× 34 580
Alexander Smith United Kingdom 13 120 0.9× 60 0.5× 25 0.2× 130 1.8× 98 1.6× 22 821
Asude Aksoy Türkiye 10 104 0.8× 187 1.5× 37 0.3× 15 0.2× 30 0.5× 36 537

Countries citing papers authored by Marwa M. M. Refaie

Since Specialization
Citations

This map shows the geographic impact of Marwa M. M. Refaie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marwa M. M. Refaie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marwa M. M. Refaie more than expected).

Fields of papers citing papers by Marwa M. M. Refaie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marwa M. M. Refaie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marwa M. M. Refaie. The network helps show where Marwa M. M. Refaie may publish in the future.

Co-authorship network of co-authors of Marwa M. M. Refaie

This figure shows the co-authorship network connecting the top 25 collaborators of Marwa M. M. Refaie. A scholar is included among the top collaborators of Marwa M. M. Refaie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marwa M. M. Refaie. Marwa M. M. Refaie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassuna, Noha A., et al.. (2023). Antibacterial effect of vitamin C against uropathogenic E. coli in vitro and in vivo. BMC Microbiology. 23(1). 112–112. 16 indexed citations
2.
Refaie, Marwa M. M., et al.. (2023). Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways. Journal of Pharmacy and Pharmacology. 75(9). 1237–1248. 3 indexed citations
3.
4.
Refaie, Marwa M. M., et al.. (2023). Molecular mechanisms mediate roflumilast protective effect against isoprenaline-induced myocardial injury. Immunopharmacology and Immunotoxicology. 45(6). 650–662. 2 indexed citations
6.
Refaie, Marwa M. M., et al.. (2021). Diacerein ameliorates benign prostatic hyperplasia with dysplastic changes in rats via modulation of IL1β and Nrf2/HO1 pathway. Minia Journal of Medical Research. 32(3). 58–61.
7.
Refaie, Marwa M. M., et al.. (2021). The IL-6/STAT Signaling Pathway and PPARα Are Involved in Mediating the Dose-Dependent Cardioprotective Effects of Fenofibrate in 5-Fluorouracil-Induced Cardiotoxicity. Cardiovascular Drugs and Therapy. 36(5). 817–827. 15 indexed citations
8.
Refaie, Marwa M. M., et al.. (2021). Dose dependent effect of cilostazol in induced testicular ischemia reperfusion via modulation of HIF/VEGF and cAMP/SIRT1 pathways. International Immunopharmacology. 101(Pt A). 108197–108197. 9 indexed citations
9.
Refaie, Marwa M. M., et al.. (2021). Dose-Dependent Cardioprotective Effect of Hemin in Doxorubicin-Induced Cardiotoxicity Via Nrf-2/HO-1 and TLR-5/NF-κB/TNF-α Signaling Pathways. Cardiovascular Toxicology. 21(12). 1033–1044. 20 indexed citations
10.
Refaie, Marwa M. M., et al.. (2021). Cardioprotective effects of bosentan in 5-fluorouracil-induced cardiotoxicity. Toxicology. 465. 153042–153042. 21 indexed citations
11.
Refaie, Marwa M. M., et al.. (2019). Mechanisms mediating the cardioprotective effect of carvedilol in cadmium induced cardiotoxicity. Role of eNOS and HO1/Nrf2 pathway. Environmental Toxicology and Pharmacology. 70. 103198–103198. 24 indexed citations
12.
Refaie, Marwa M. M., et al.. (2019). Role of ATP-Sensitive Potassium Channel (KATP) and eNOS in Mediating the Protective Effect of Nicorandil in Cyclophosphamide-Induced Cardiotoxicity. Cardiovascular Toxicology. 20(1). 71–81. 34 indexed citations
13.
Refaie, Marwa M. M., et al.. (2018). Role of PPAR‐α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats. Fundamental and Clinical Pharmacology. 32(6). 617–626. 7 indexed citations
14.
Abdel-Gaber, Seham A., et al.. (2018). Mechanism mediating the protective effect of diacerein in ischemia-reperfusion-induced testicular injury in rats. Life Sciences. 209. 57–62. 47 indexed citations
16.
Refaie, Marwa M. M., et al.. (2018). Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways. Environmental Toxicology and Pharmacology. 58. 212–219. 35 indexed citations
17.
Refaie, Marwa M. M., et al.. (2017). Effect of Telmisartan on Ischemia Reperfusion Induced Testicular Injury in Rats. 7. 2 indexed citations
18.
Refaie, Marwa M. M., et al.. (2017). Role of Ketotifen in Methotrexate-induced Nephrotoxicity in Rats. 7. 4 indexed citations
19.
Refaie, Marwa M. M., et al.. (2017). Diacerein inhibits Estradiol-benzoate induced cervical hyperkeratosis in female rats. Biomedicine & Pharmacotherapy. 95. 223–229. 8 indexed citations
20.
Refaie, Marwa M. M., et al.. (2017). The role of interleukin‐1b and its antagonist (diacerein) in estradiol benzoate‐induced endometrial hyperplasia and atypia in female rats. Fundamental and Clinical Pharmacology. 31(4). 438–446. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026